FindTrial
Sign In

Preoperative Contrast Enhanced US Imaging to Predict Early Recurrence of HCC after Curative Resection or Ablation

Hepatocellular Carcinoma after Curative Resection: Preoperative Contrast Enhanced Ultrasonography to Predict Early Recurrence

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-DDD-16010089
Enrollment
Unknown
Registered
2016-12-05
Start date
2017-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatocellular Carcinoma

Interventions

Gold Standard:
Index test:

Sponsors

The First Affiliated Hospital of Sun Yat-Sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-80 years old; 2. underwent preoperative CEUS and CT/MR; 3. underwent radical resection/ablation; 4. postoperative pathologic examination shows a single HCC; 5. follow up not less than 2 years.

Exclusion criteria

Exclusion criteria: 1. had received local-regional therapy such as chemoembolization or chemoradiation before surgery; 2. Metastasis; 3. had ruptured HCC; 4.Portal vein invasion.

Design outcomes

Primary

MeasureTime frame
probability of recurrence;—

Countries

China

Contacts

Public ContactMing-De Lu

The First Affiliated Hospital of Sun Yat-Sen University

lumd@live.com+86 13808811838

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 5, 2026